These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31749595)

  • 41. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study.
    Salman T; Kazaz SN; Varol U; Oflazoglu U; Unek IT; Kucukzeybek Y; Alacacioglu A; Atag E; Semiz HS; Cengiz H; Oztop I; Tarhan MO
    Chemotherapy; 2016; 61(6):281-6. PubMed ID: 27070366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumors.
    Raoof M; Jutric Z; Melstrom LG; Lee B; Li D; Warner SG; Fong Y; Singh G
    Surgery; 2019 Apr; 165(4):760-766. PubMed ID: 30447803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
    Zhou B; Zhan C; Xiang J; Ding Y; Yan S
    BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.
    Wong J; Fulp WJ; Strosberg JR; Kvols LK; Centeno BA; Hodul PJ
    Am J Surg; 2014 Nov; 208(5):775-780. PubMed ID: 24997491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophil Extracellular Traps and Macrophage Extracellular Traps Predict Postoperative Recurrence in Resectable Nonfunctional Pancreatic Neuroendocrine Tumors.
    Xu SS; Li H; Li TJ; Li S; Xia HY; Long J; Wu CT; Wang WQ; Zhang WH; Gao HL; Han X; Ye LY; Lin X; Xu HX; Yu XJ; Liu L
    Front Immunol; 2021; 12():577517. PubMed ID: 34084158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumors.
    Genç CG; Jilesen APJ; Nieveen van Dijkum EJM; Klümpen HJ; van Eijck CHJ; Drozdov I; Malczewska A; Kidd M; Modlin I
    J Surg Oncol; 2018 Jul; 118(1):37-48. PubMed ID: 30114319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Assessment value of preoperative platelet-lymphocyte ratio in the prognosis of patients with gastric mixed adenoneuroendocrine carcinoma].
    Cao L; Lu J; Lin J; Zheng C; Li P; Xie J; Wang J; Chen Q; Lin M; Tu R; Huang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1252-1257. PubMed ID: 27928795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.
    Sallinen VJ; Le Large TYS; Tieftrunk E; Galeev S; Kovalenko Z; Haugvik SP; Antila A; Franklin O; Martinez-Moneo E; Robinson SM; Panzuto F; Regenet N; Muffatti F; Partelli S; Wiese D; Ruszniewski P; Dousset B; Edwin B; Bartsch DK; Sauvanet A; Falconi M; Ceyhan GO; Gaujoux S;
    HPB (Oxford); 2018 Mar; 20(3):251-259. PubMed ID: 28988702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased neutrophil-lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification.
    Miura T; Ohtsuka H; Aoki T; Aoki S; Hata T; Takadate T; Maeda S; Ariake K; Kawaguchi K; Masuda K; Ishida M; Mizuma M; Nakagawa K; Morikawa T; Fujishima F; Kamei T; Sasano H; Unno M
    BMC Surg; 2021 Mar; 21(1):176. PubMed ID: 33789657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
    Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
    Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm.
    Mirkin KA; Hollenbeak CS; Wong J
    J Surg Res; 2017 May; 211():206-214. PubMed ID: 28501118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.
    d'Engremont C; Vernerey D; Pointet AL; Simone G; Fein F; Heyd B; Koch S; Vuitton L; Kim S; Jary M; Lamfichek N; Turco C; Lakkis Z; Berger A; Bonnetain F; Taieb J; Bachellier P; Borg C
    BMC Cancer; 2016 Oct; 16(1):823. PubMed ID: 27782813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-Free DNA and Clinical Characteristics in Patients with Small Intestinal or Pancreatic Neuroendocrine Tumors.
    Oversoe SK; Sorensen BS; Tabaksblat EM; Gronbaek H; Kelsen J
    Neuroendocrinology; 2022; 112(1):43-50. PubMed ID: 33461190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-Functional Pancreatic Neuroendocrine Tumor.
    Zhang WH; Wang WQ; Gao HL; Xu SS; Li S; Li TJ; Han X; Xu HX; Li H; Jiang W; Ye LY; Lin X; Wu CT; Yu XJ; Liu L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32285127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet indices in differential diagnosis of pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
    Varol E
    Eur J Intern Med; 2014 Jul; 25(6):e82. PubMed ID: 24582330
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
    Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
    Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Talamonti MS; Hall CR; Thurow TA; Gage MK; Stocker SJ; Lapin B; Wang E; Silverstein JC; Mangold K; Odeleye M; Kaul KL; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA
    Surgery; 2014 Dec; 156(6):1504-10; discussion 1510-1. PubMed ID: 25456943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately.
    Yoshida T; Hijioka S; Hosoda W; Ueno M; Furukawa M; Kobayashi N; Ikeda M; Ito T; Kodama Y; Morizane C; Notohara K; Taguchi H; Kitano M; Yane K; Tsuchiya Y; Komoto I; Tanaka H; Tsuji A; Hashigo S; Mine T; Kanno A; Murohisa G; Miyabe K; Takagi T; Matayoshi N; Sakaguchi M; Ishii H; Kojima Y; Matsuo K; Yoshitomi H; Nakamori S; Yanagimoto H; Yatabe Y; Furuse J; Mizuno N
    Ann Surg Oncol; 2019 May; 26(5):1385-1393. PubMed ID: 30863939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
    Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
    Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Ji WH; Jiang YH; Ji YL; Li B; Mao WM
    Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.